Predictors of renal recovery in patients with pre-orthotopic liver transplant (OLT) renal dysfunction

BMC Nephrology

Volumn 14, Issue 1, 2013, Pages

  Iglesias, Jose ^a,b,c   Frank, Elliot ^b   Mehandru, Sushil ^c   Davis, John M ^b   Levine, Jerrold S ^d,e  

^a UMDNJ School of Osteopathic Medicine   (United States)

^b JERSEY SHORE UNIVERSITY MEDICAL CENTER   (United States)

^c ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^e JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; BASILIXIMAB; CREATININE; CYCLOSPORIN; CYCLOSPORIN A; DACLIZUMAB; OKT 3; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ALLOGRAFT; ARTICLE; ARTIFICIAL VENTILATION; COMORBIDITY; CONTROLLED STUDY; CONVALESCENCE; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DATA BASE; DIALYSIS; END STAGE LIVER DISEASE; FEMALE; GLOMERULUS FILTRATION RATE; HOSPITAL DISCHARGE; HUMAN; INDEPENDENT VARIABLE; INTENSIVE CARE UNIT; KIDNEY DONOR; KIDNEY FAILURE; KIDNEY FUNCTION; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; REGISTRATION; RENAL GRAFT DYSFUNCTION; RENAL REPLACEMENT THERAPY; SURVIVAL TIME; COHORT ANALYSIS; KIDNEY DISEASES; KIDNEY FUNCTION TEST; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; RETROSPECTIVE STUDY; TRENDS;

ADULT; COHORT STUDIES; FEMALE; HUMANS; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RECOVERY OF FUNCTION; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDIES;

EID: 84880119736     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-14-147     Document Type: Article

References (41)

1. Pathophysiology of renal disease associated with liver disorders: implications for liver transplantation. Davis CL, Gonwa TA, Wilkinson AH, Part I Liver Transpl 2002 8 91 9109 10.1053/jlts.2002.31516 (Pubitemid 34202136)
2. Hepatorenal syndrome: a severe, but treatable, cause of kidney failure in cirrhosis. Fagundes C, Ginès P, Am J Kidney Dis 2012 59 874 885 10.1053/j.ajkd.2011.12.032 22480795
3. Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: where will MELD lead us? Gonwa TA, McBride MA, Anderson K, Mai ML, Wadei H, Ahsan N, Am J Transplant 2006 6 2651 2659 10.1111/j.1600-6143.2006.01526.x 16939515 (Pubitemid 44571685)
4. Simultaneous liver-kidney transplantation: evaluation to decision making. Davis CL, Feng S, Sung R, Wong F, Goodrich NP, Melton LB, Reddy KR, Guidinger MK, Wilkinson A, Lake J, Am J Transplant 2007 7 1702 1709 10.1111/j.1600-6143. 2007.01856.x 17532752 (Pubitemid 46905445)
5. Pretransplant predictors of recovery of renal function after liver transplantation. Northup PG, Argo CK, Bakhru MR, Schmitt TM, Berg CL, Rosner MH, Liver Transpl 2010 16 440 446 20205164
6. The course of type 1 hepato-renal syndrome post liver transplantation. Marik PE, Wood K, Starzl TE, Nephrol Dial Transplant 2006 21 478 482 10.1093/ndt/gfi212 16249201 (Pubitemid 43160005)
7. Renal function outcomes following liver transplantation and combined liver-kidney transplantation. Pham PT, Pham PC, Wilkinson AH, Nat Clin Pract Nephrol 2007 3 507 514 10.1038/ncpneph0574 17717563 (Pubitemid 47313029)
8. Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis. Wong F, Nadim MK, Kellum JA, Salerno F, Bellomo R, Gerbes A, Angeli P, Moreau R, Davenport A, Jalan R, Ronco C, Genyk Y, Arroyo V, Gut 2011 60 702 709 10.1136/gut.2010.236133 21325171
9. A new look at renal dysfunction in the cirrhotic patient. Francoz C, Durand F, Crit Care 2012 16 118 10.1186/cc11412 22385933
10. Epatorenal syndrome: the 8th international consensus conference of the Acute Dialysis Quality Initiative (ADQI) Group. Nadim MK, Kellum JA, Davenport A, Wong F, Davis C, Pannu N, Tolwani A, Bellomo R, Genyk YS, Crit Care 2012 16 1 R23
11. Kidney allocation to liver transplant candidates with renal failure of undetermined etiology: role of percutaneous renal biopsy. Wadei HM, Geiger XJ, Cortese C, Mai ML, Kramer DJ, Rosser BG, Keaveny AP, Willingham DL, Ahsan N, Gonwa TA, Am J Transplant 2008 8 2618 2626 10.1111/j.1600-6143.2008.02426.x 19032225
12. The spectrum of renal lesions in patients with cirrhosis: a clinicopathological study. Trawalé JM, Paradis V, Rautou PE, Francoz C, Escolano S, Sallée M, Durand F, Valla D, Lebrec D, Moreau R, Liver Int 2010 30 725 732 10.1111/j.1478-3231.2009.02182.x 20040048
13. Transplantation: impact of pretransplant renal insufficiency. Bahirwani R, Campbell MS, Siropaides T, Markmann J, Olthoff K, Shaked A, Bloom RD, Reddy KR, Liver Transpl 2008 14 665 671 10.1002/lt.21367 18433034 (Pubitemid 351696279)
14. Renal function after orthotopic liver transplantation is predicted by duration of pretransplantation creatinine elevation. Campbell MS, Kotlyar DS, Brensinger CM, Lewis JD, Shetty K, Bloom RD, Markmann JF, Olthoff KM, Shaked A, Reddy KR, Liver Transpl 2005 11 1048 1055 10.1002/lt.20445 16123966 (Pubitemid 41341753)
15. Proceedings of Consensus Conference on Simultaneous Liver Kidney Transplantation (SLK). Eason JD, Gonwa TA, Davis CL, Sung RS, Gerber D, Bloom RD, Am J Transplant 2008 8 2243 2251 10.1111/j.1600-6143.2008.02416.x 18808402
16. Outcomes for hepatorenal syndrome and acute kidney injury in patients undergoing liver transplantation: a single-center experience. Shusterman B, Mchedishvili G, Rosner MH, Transplant Proc 2007 39 1496 1500 10.1016/j.transproceed.2007.01.087 17580171 (Pubitemid 46907933)
17. Levitsky J, Baker T, Ahya SN, Levin ML, Friedewald J, Gallon L, Ho B, Skaro A, Krupp J, Wang E, Spies SM, Salomon DR Abecassis MM: Outcomes and Native Renal Recovery Following Simultaneous Liver-Kidney Transplantation. Am J Transplant 2012
18. Intensive care management of liver transplanted patients. Feltracco P, Barbieri S, Galligioni H, Michieletto E, Carollo C, Ori C, World J Hepatol 2011 3 61 71 10.4254/wjh.v3.i3.61 21487537
19. Risk factors of acute renal failure after liver transplantation. Cabezuelo JB, Ramírez P, Ríos A, Acosta F, Torres D, Sansano T, Pons JA, Bru M, Montoya M, Bueno FS, Robles R, Parrilla P, Kidney Int 2006 69 1073 1080 10.1038/sj.ki.5000216 16528257 (Pubitemid 43372183)
20. Risk factors for acute renal failure requiring dialysis after liver transplantation. Bilbao I, Charco R, Balsells J, Lazaro JL, Hidalgo E, Llopart L, Murio E, Margarit C, Clin Transplant 1998 12 123 129 9575400 (Pubitemid 128721313)
21. Donor age and outcome of liver transplantation. Hoofnagle JH, Lombardero M, Zetterman RK, Lake J, Porayko M, Everhart J, Belle SH, Detre KM, Hepatology 1996 24 89 96 10.1002/hep.510240116 8707288 (Pubitemid 26249418)
22. Donor age as a predictor of risk for short-term outcomes after liver transplant. Macedo FI, Miranda LE, Fernandes JL, Pádua TC, Figueroa JN, Neto OL, Lacerda CM, Exp Clin Transplant 2010 8 202 209 20716037
23. Correlation between donor age and the pattern of liver graft recovery after transplantation. Yersiz H, Shaked A, Olthoff K, Imagawa D, Shackleton C, Martin P, Busuttil RW, Transplantation 1995 60 790 794 7482736
24. Donor age affects liver regeneration during early period in the graft liver and late period in the remnant liver after living donor liver transplantation. Tanemura A, Mizuno S, Wada H, Yamada T, Nobori T, Isaji S, World J Surg 2012 36 1102 1111 10.1007/s00268-012-1496-1 22374540
25. Exaggerated up-regulation of tumor necrosis factor alpha-dependent apoptosis in the older mouse liver following reperfusion injury: targeting liver protective strategies to patient age. Selzner M, Selzner N, Chen L, Borozan I, Sun J, Xue-Zhong M, Zhang J, McGilvray ID, Liver Transpl 2009 15 1594 1604 10.1002/lt.21864 19877208
26. Lower expression of Nrf2 mRNA in older donor livers: a possible contributor to increased ischemia-reperfusion injury? Zaman MB, Leonard MO, Ryan EJ, Nolan NP, Hoti E, Maguire D, Mulcahy H, Traynor O, Taylor CT, Hegarty JE, Geoghegan JG, O'Farrelly C, Transplantation 2007 84 1272 1278 10.1097/01.tp.0000288229.53064.e2 18049112 (Pubitemid 351339315)
27. Use of older donor livers is associated with more extensive ischemic damage on intraoperative biopsies during liver transplantation. Deschênes M, Forbes C, Tchervenkov J, Barkun J, Metrakos P, Tector J, Alpert E, Liver Transpl Surg 1999 5 357 361 10.1002/lt.500050501 10477834 (Pubitemid 29437010)
28. Liver grafts from selected older donors do not have significantly more ischaemia reperfusion injury. Martins PN, Chang S, Mahadevapa B, Martins AB, Sheiner P, HPB (Oxford) 2011 13 212 220 10.1111/j.1477-2574.2010.00275.x
29. Massicotte L, Denault AY, Beaulieu D, Thibeault L, Hevesi Z, Nozza A, Lapointe R, Roy A, Transfusion Rate for 500 Experience of One Liver Transplantation Center. Transplantation: Consecutive Liver Transplantations 2012
30. Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome. Gluud LL, Christensen K, Christensen E, Krag A, Hepatology 2010 51 576 584 10.1002/hep.23286 19885875
31. Terlipressin improves renal function in patients with cirrhosis and ascites without hepatorenal syndrome. Krag A, Møller S, Henriksen JH, Holstein-Rathlou NH, Larsen FS, Bendtsen F, Hepatology 2007 46 1863 1871 10.1002/hep.21901 18027874
32. Effect of low central venous pressure and phlebotomy on blood product transfusion requirements during liver transplantations. Massicotte L, Lenis S, Thibeault L, Sassine MP, Seal RF, Roy A, Liver Transpl 2006 12 117 123 10.1002/lt.20559 16382461
33. Survival rate changes with transfusion of blood products during liver transplantation. Massicotte L, Sassine MP, Lenis S, Seal RF, Roy A, Can J Anaesth 2005 52 148 155 10.1007/BF03027720 15684254 (Pubitemid 40467971)
34. Perioperative use of continuous renal replacement therapy for orthotopic liver transplantation. Douthitt L, Bezinover D, Uemura T, Kadry Z, Shah RA, Ghahramani N, Janicki PK, Transplant Proc 2012 44 1314 1317 10.1016/j. transproceed.2012.01.142 22664007
35. Renal insufficiency after liver transplantation in the MELD era compared to the pre-MELD era. Feng ZZ, Tang J, Kim DY, Brown K, Abouljoud M, Gordon S, Yoshida A, Huang MA, Divine G, Moonka DK, Clin Transplant 2009 23 637 642 10.1111/j.1399-0012.2009.01020.x 19573089
36. Impact of implementation of the MELD scoring system on the prevalence and incidence of chronic renal disease following liver transplantation. Machicao VI, Srinivas TR, Hemming AW, Soldevila-Pico C, Firpi RJ, Reed AI, Morelli GJ, Nelson DR, Abdelmalek MF, Liver Transpl 2006 12 754 761 10.1002/lt.20686 16528716
37. Body surface area index predicts outcome in orthotopic liver transplantation. Fukazawa K, Nishida S, Volsky A, Tzakis AG, Pretto EA, J Hepatobiliary Pancreat Sci 2011 18 216 225 10.1007/s00534-010-0334-9 20936303
38. Obesity, inflammation, and the potential application of pharmaconutrition. Cave MC, Hurt RT, Frazier TH, Matheson PJ, Garrison RN, McClain CJ, McClave SA, Nutr Clin Pract 2008 23 16 34 10.1177/011542650802300116 18203961 (Pubitemid 351438965)
39. Renal function after liver transplantation: calcineurin inhibitor nephrotoxicity. Ziolkowski J, Paczek L, Senatorski G, Niewczas M, Oldakowska-Jedynak U, Wyzgal J, Sanko-Resmer J, Pilecki T, Zieniewicz K, Nyckowski P, Patkowski W, Krawczyk M, Transplant Proc 2003 35 2307 2309 10.1016/S0041-1345(03)00786-3 14529923 (Pubitemid 37194399)
40. Thymoglobulin and ischemia reperfusion injury in kidney and liver transplantation. Mehrabi A, Mood Z, Sadeghi M, Schmied BM, Müller SA, Welsch T, Kuttymuratov G, Wente MN, Weitz J, Zeier M, Morath C, Riediger C, Schemmer P, Encke J, Büchler MW, Schmidt J, Riediger C, Schemmer P, Encke J, Büchler MW, Schmidt J, Nephrol Dial Transplant 2007 22 Suppl 8 &22iii54 viii60 17890265
41. Evaluation of native kidney recovery after simultaneous liver-kidney transplantation. Francis JM, Palmer MR, Donohoe K, Curry M, Johnson SR, Karp SJ, Evenson AR, Pavlakis M, Hanto DW, Mandelbrot DA, Transplantation 2012 93 530 535 10.1097/TP.0b013e3182449161 22245875